Duchenne型肌营养不良患儿营养状况及其影响因素的相关性

李丽, 牟瑛, 孙岩峰, 李卉

武警医学 ›› 2015, Vol. 26 ›› Issue (5) : 460-462.

PDF(683 KB)
PDF(683 KB)
武警医学 ›› 2015, Vol. 26 ›› Issue (5) : 460-462.
论著

Duchenne型肌营养不良患儿营养状况及其影响因素的相关性

  • 李丽1, 牟瑛2, 孙岩峰3, 李卉1
作者信息 +

Nutritional assessment and influencing factors in children with Duchenne muscular dystrophy:a relevant study

  • LI Li1,MU Ying2, SUN Yanfeng3, LI Hui1
Author information +
文章历史 +

摘要

目的 探讨Duchenne型肌营养不良(duchenne muscular dystrophy,DMD)患儿的营养状况与影响因素之间的关系,为该病的营养及综合治疗提供依据。方法 回顾性分析武警总医院神经内科联合门诊就诊的DMD患儿154例为研究对象,分别计算年龄别体重(WAZ)、年龄别身高(HAZ)、身高别体重(WHZ)、年龄别体重(BAZ)指数四项Z评分,将Z评分与影响因素间进行t检验和Spearman 等级相关分析。结果 Z评分中WHZ与BAZ均值均为正值,WAZ与HAZ均值为负值,在行走早期(<9岁)即可表现出发育迟缓,至行走晚期(≥9岁)时,低体重和发育迟缓发生率均较高(P<0.05)。DMD患儿低体重、生长迟缓、消瘦、肥胖的发生率分别为4.6%、20.1%、3.9%、13.0%,其中行走早期的患儿肥胖的发生率较高(16.9%),而行走晚期的患儿生长迟缓发生率高达30.8%。Z评分与部分影响因素之间存在相关关系,其中WAZ和HAZ与家庭月收入呈正相关(P<0.05)。结论 DMD患儿的低体重及营养不良发生率较高,Z评分处在较低水平,应采取积极措施提高临床医师及患儿家属对DMD营养治疗的认识。

Abstract

Objective To investigate the relationship between nutritional status and influencing factors of children with Duchenne muscular dystrophy (DMD), providing the basis for nutritional and integrated caring of this disease. Methods The study included 154 children with DMD who received treatments at the Department of Neurology of the General Hospital of the Chinese People’s Armed Police Force along with outpatient clinics from 2013 through 2014. Z-scores (WAZ, HAZ, WHZ and BAZ) were calculated, ttest and Spearman rank correlation analysis were conducted between Z-scores and influencing factors. Results In Z-scores, means of both WHZ and BAZ were positive, while those of both WAZ and HAZ were negative. Growth retardation was present at the early stage of walking (<9 year-old); there was a high incidence of low body weight and growth retardation (P<0.05) till the late stage of walking (≥9 year-old). For children with DMD, incidence rates of low body weight, growth retardation, emaciation and obesity were 4.6%, 20.1%, 3.9% and 13.0%, respectively. Especially, children at the early stage of walking had a high incidence of obesity (16.9%), while the incidence of growth retardation was up to 30.8% in those at the late stage of walking. Z-scores correlated with some influencing factors, WAZ and HAZ and family monthly income was positively related among them (P<0.05). Conclusions The nutritional status in children with DMD is unoptimistic with Z-scores at a low level; positive measures should be taken to allow clinicians and children’s parents to improve the knowledge of the nutritional therapy for DMD, providing a good basis for sequential treatment of this disease.

关键词

肌营养不良 / 杜氏 / 营养状况 / Z评分

Key words

Duchenne / muscular dystrophy / nutritional status / Z score

引用本文

导出引用
李丽, 牟瑛, 孙岩峰, 李卉. Duchenne型肌营养不良患儿营养状况及其影响因素的相关性[J]. 武警医学. 2015, 26(5): 460-462
LI Li,MU Ying, SUN Yanfeng, LI Hui. Nutritional assessment and influencing factors in children with Duchenne muscular dystrophy:a relevant study[J]. Medical Journal of the Chinese People Armed Police Forces. 2015, 26(5): 460-462
中图分类号: R723.2   

参考文献

[1] Helderman Enden A T,Madan K,Breuning M H,et al. An urgent need for a change in policy revealed by a study on prenatal testing for Duchenne muscular dystrophy[J].Eur J Hum Genet,2012,2:123.
[2] 张 成,杨 娟.重视Duchenne型肌营养不良症的康复治疗[J].中国现代神经疾病杂志,2012,12(3):261-265.
[3] Moxley R T, Ashwal S, Pandya S, et al. Practice parameter: corticosteroid treatment of Duchenne dystrophy. Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society [J]. Neurol, 2005, 64(1):13-20.
[4] Manzur A Y, Kuntzer T, Pike M, et al. Glucocorticoid corticosteroids for Duchenne muscular dystrophy [J]. Cochrane Database Syst Rev, 2008, 23(1): 3725.
[5] Manzur A Y, Muntoni F. Diagnosis and new treatments in muscular dystrophies [J]. J Neurol Neurosurg Psychiatry, 2009, 80(7): 706-714.
[6] Bushby K, Finkel R, Birnkrant D J, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: implemenetation of multidisciplinary care [J]. Lancet Neurol, 2010, 9 (2): 177-189.
[7] Bushby K, Finkel R, Birnkrant D J, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management [J]. lancet Neurol, 2010, 9(1): 77-93.
[8] Moxley R T, Pandya S, Ciafaloni E, et al. Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: Implications for management [J]. J Child Neurol, 2010, 25(9): 1116-1129.
[9] 李作汗,张 平.神经肌肉疾病的临床与病理[M]. 北京:人民卫生出版社,2007:11-90.
[10] 董为伟. 神经系统疾病治疗学[M]. 北京:科学出版社,2007:723.
[11] Rodriguez Oliveros G, Haines J, Ortega Altamirano D, et al. Obesity determinants in Mexican preschool children: parental perceptions and practices related to feeding and physical activity [J]. Arch Med Res, 2011, 42(6): 532-539.

基金

武警总医院重点课题项目(WZ201210)

PDF(683 KB)

Accesses

Citation

Detail

段落导航
相关文章

/